Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR)

Scandinavian Journal of Rheumatology

Volumn 27, Issue 5, 1998, Pages 363-367

  Xu, J W ^a,b,c   Li, T F ^a,b   Partsch, G ^d   Ceponis A ^a   Santavirta, S ^b   Konttinen, Y T ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c ORTON Invalid Foundation   (Finland)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Aseptic loosening; Immunohistochemistry; Interleukin 11; Total hip replacement

Indexed keywords

CYTOKINE; INTERLEUKIN 11;

ADULT; AGED; ARTHRITIS; ARTICLE; BONE REMODELING; CLINICAL ARTICLE; ENDOPROSTHESIS LOOSENING; FEMALE; HIP DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT PROSTHESIS; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ASEPSIS; FEMALE; HIP PROSTHESIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-11; JOINT CAPSULE; MALE; MIDDLE AGED; OSTEOLYSIS; PROSTHESIS FAILURE; SYNOVIAL MEMBRANE;

EID: 0031724622     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749850154393     Document Type: Article

References (25)

1. Beckengaugh RD, Ilstrup DM. Total hip arthroplasty, a review of three hundred and thirty-three cases with long follow-up. J Bone Joint Surg 1978;60-A:306-13.
2. Cornell CN, Ranawat CS. Survivorship analysis of total hip replacement: results in a series of active patients who were less than fifty-five years old. J Bone Joint Surg 1986;68-A:1430-4.
3. Santavirta S, Konttinen YT, Bergroth V, Eskola A, Tallroth K, Lindholm TS. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg 1990;72-A:252-8.
4. Eftekhar NS, Nercessian O. Incidence and mechanism of failure of cemented acetabular component in total hip arthroplasty. Orthop Clin North Am 1988;19:557-66.
5. Lombardi AV Jr, Mallory TH, Vaughn BK, Drouillard P. Aseptic loosening in total hip arthroplasty secondary to osteolysis induced by wear debris from titanium-alloy modular femoral heads. J Bone Joint Surg 1989;71-A:1337-42.
6. Goldring SR, Schiller AL, Roelke M, O'Neil CM, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacement and its proposed role in bone lysis. J Bone Joint Surg 1983;65-A:575-84.
7. Santavirta S, Ceponis A, Solovieva SA, Hurri H, Jin J, Takagi M. et al. Periprosthetic microvasculature in loosening of total hip replacement. Arch Orthop Trauma Surg 1996;115:286-9.
8. Sabokbar A, Rushton N. Role of inflammatory mediators and adhesion molecules in the pathogenesis of aseptic loosening in total hip arthroplasties. J Arthroplasty 1995;10:810-6.
9. Goodman SB, Knoblich G, O'Connor M, Song Y, Huie P, Sibley R. Heterogeneity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses. J Biomed Mater Res 1996;31:421-8.
10. Takagi M. Neutral proteinases and their inhibitors in the loosening of total hip prostheses. Acta Orthop Scand 1996;Suppl 271:1-29.
11. Konttinen YT, Xu J-W, Pätiälä H, Imai S, Waris V, Li T-F, et al. Cytokines in aseptic loosening of total hip replacement. Current Orthop 1997;11:40-7.
12. Yang YC. Interleukin 11: an overview. Stem Cells 1993;11:474-86.
13. Quesniaux VF. Interleukin 11. Leuk Lymphoma 1994;14:241-9.
14. Neben S, Turner K. The biology of interleukin II. Stem Cells 1993;11Suppl 2:156-62.
15. Goldman SJ. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells 1995;13:462-71.
16. Elias JA, Tang W, Horowitz MC. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endorinology 1995;136:489-98.
17. Girasole G, Passeri G, Jilka RL, Manolagas SC. Interleukin-II: a new cytokine critical for osteoclast development. J Clin Invest 1994;93:1516-24.
18. Hughes FJ, Howells GL. Interleukin-11 inhibits bone formation in vitro. Calcif Tissue Int 1993;53:362-4.
19. Konttinen YT, Hukkanen M, Segerberg M, Rees R, Kempinen P, Sorsa T, et al. Relationship between neuropeptide immunoreactive nerves and inflammatory cells in adjuvant arthritic rats. Scand J Rheumatol 1992;21:55-9.
20. Friedman RJ, Black J, Galante JO, Jacobs JJ, Skinner HB. Current concepts in orthopaedic biomaterials and implant fication. J Bone Joint Surg 1993;75-A:1086-109.
21. Goldring SR, Clark CR, Wright TM. The problem in total joint arthroplasty. J Bone Joint Surg 1993;75-A:799-801.
22. Jacobs JJ, Shanbhag A, Giant TT, Black J, Galante JO. Wear debris in total joints replacements. J Am Acad Orthop Surg 1994;2:212-20.
23. Yao J, Giant TT, Lark MW, Mikecz K, Jacobs JJ, Hutchinson NI, et al. The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particles. J Bone Miner Res 1995;10:1417-27.
24. Manlapaz M, Maloney WJ, Smith RL. In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. J Orthop Res 1996;14:465-72.
25. Paul SR, Bennett F, Calvetti JA, Kellcher K, Wood CR, O'Hara Jr. RM, et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990;87:7512-6.